It turned out that AKT1 or CASP3 interacted with luteolin, wogonin, and kaempferol, respectively, unveiling that AKT1 and CASP3 may be the key targets of luteolin, wogonin, and kaempferol against FRNS. This evidence concerns the gene CASP3 and Fryns syndrome.